Meet-the-Expert |
Clinical Trial Update |
Science in Progress |
Simultaneous Sessions I |
Hematolgy-in-Focus Session |
Clinical Trial Update |
Simultaneous Sessions II |
Lunch Debate |
EHA / ASH Joint Symposium on Stem Cell Banking |
EHA Business Meeting |
Presidential Symposium |
Plenary Session I |
Poster Session II
HEMATOLOGY-IN-FOCUS SESSION
09.30 - 10.15 hours, Room: Mozart I
PHARMACOGENOMICS
Chair: M. Hassan (Karolinska Institute, Stockholm, Sweden)
PHARMACOGENOMICS IN ALL- A MODEL FOR IMPROVING OUTCOME
IN HEMATOLOGIC MALIGANCIES
L. Kager (St. Anna Children’s Hospital, Vienna, Austria)
PHARMACOGENOMICS IN MYELOMA
K. Stewart (Mayo Clinic, Rochester, USA)
HEMATOLOGY-IN-FOCUS SESSION
09.30 - 10.15 hours, Room: Mozart II
BIOLOGY OF FOLLICULAR LYMPHOMA
Chair: J. Cabecadas (Instituto Portugues de Oncologia Francisco Gentil,
Lisbon, Portugal)
MICRO-ARRAYS IN FOLLICULAR LYMPHOMA: WHAT HAVE WE LEARNED?
D. de Jong (Netherlands Cancer Institute, Amsterdam, The Netherlands)
THE IMMUNE PATHOGENESIS OF FOLLICULAR LYMPHOMA
A. Lister (St. Bartholomew’s Hospital, London, United Kingdom)
HEMATOLOGY-IN-FOCUS SESSION
09.30 - 10.15 hours, Room: Mozart III
COAGULATION
Chair: K. Preissner (Medical University Giessen, Giessen, Germany)
INTRINSIC PATHWAY PROTEASES IN MOUSE MODELS OF VASCULAR
THROMBOSIS
D. Gailani (Vanderbilt University, Nashville, USA)
THE PROTHROMBOTIC ROLE OF FIBRINOGEN IN COAGULATION
S. Duga (University of Milan, Milan, Italy)
HEMATOLOGY-IN-FOCUS SESSION
09.30 - 10.15 hours, Room: Strauss I
THE ORIGIN OF LYMPHOPROLIFERATIVE DISEASE
Chair: E. MacIntyre (Hopital Necker/Enfants Malades, Paris, France)
NORMAL AND MALIGNANT B-CELLS
M. Busslinger (University of Vienna, Vienna, Austria)
MECHANISMS OF CHROMOSOMAL TRANSLOCATIONS
B. Nadel (Université de la Méditerranée, Marseille, France)
HEMATOLOGY-IN-FOCUS SESSION
09.30 - 10.15 hours, Room: Strauss II
MLL IN NORMAL HEMOPOIESIS AND ACUTE LEUKEMIA
Chair: M. Alberich Jorda (Harvard Medical School, Boston, USA)
CHROMATIN CONTROL OF GENE EXPRESSION AND THE ROLE OF MLL
R. Slany (Friederich Alexander University Erlangen, Erlangen, Germany)
ONCOGENIC MECHANISMS MEDIATED BY MLL ONCOPROTEINS
E. So (The Institute of Cancer Research, London, United Kingdom)
HEMATOLOGY-IN-FOCUS SESSION
09.30 - 10.15 hours, Room: Strauss III
T CELLS AND THE INTERFERON PATHWAY IN MARROW FAILURE
Chair: A. Wodnar-Filipowicz (University Hospital Basel, Basel, Switzerland)
INTERFERON-MEDIATED SIGNALLING AND MARROW FAILURE
L. Platanias (Feinberg School of Medicine, Chicago, USA)
MECHANISMS OF T CELL ACTIVATION IN APLASTIC ANEMIA
J. Maciejewski (Cleveland Clinic Taussig Cancer Center, Cleveland, USA)
